DIESSE is formerly owned by ARCHIMED, through MED Platform I, since 2019.

When did ARCHIMED acquire DIESSE?

ARCHIMED acquired DIESSE in 2019 and exited after 6 years.

Has DIESSE been sold?

Yes. DIESSE was exited in 2025 via Secondary.

Home/Companies/MedTech/DIESSE

DIESSE

MedTech·

Italy·Exited 2025·Held 6yr

DIESSE is a diagnostics company, headquartered in Italy.

Entry

2019

Hold

6yr

Exit

2025

Est. EV

–

Investor

ARCHIMED

Key facts

HQItaly

SectorDiagnostics

DIESSE counts over 40 international patents, with products sold in over 100 countries. Since 2023, DIESSE operates from the new Biotech…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from MED Platform I

Other portfolio companies in the same fund.

Ad-Tech Medical Instrument

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Villard

Active

Yotta Capital Partners

France· 2026

Amoena

Active

Apera Asset Management

Germany· 2025

Circlesafe

Active

Odyssée VentureFrance

Last updated April 2026 · Sourced from public filings